NCT06068543View on ClinicalTrials.gov

Reducing Frailty for Older Cancer Survivors Using Supplements II

PHASE2RecruitingINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

January 1, 2030

Study Completion Date

December 31, 2030

Conditions
FrailtyInflammation
Interventions
DRUG

Epigallocatechin-3-Gallate (EGCG)

800mg Epigallocatechin-3-Gallate (EGCG)

DRUG

Microcrystalline cellulose (MCC)

800mg microcrystalline cellulose (MCC)

DIETARY_SUPPLEMENT

Ascorbic Acid (Vitamin C)

250mg Ascorbic Acid (Vitamin C) taken one time daily for 12 weeks

Trial Locations (1)

14627

RECRUITING

University of Rochester, Rochester

All Listed Sponsors
lead

University of Rochester

OTHER